Modernizing Clinical Research Through New Technologies, Contracting, and Pricing

Crucial Data Solutions fully supports the FDA’s push to modernize clinical trials using mobile and digital health technologies (DHTs) to speed up medical product development and lower costs. But regulatory guidance alone isn’t enough to drive meaningful change. The FDA’s mandate should be seen as a call to action for private industry to adopt modern technologies that replace outdated business models and reduce costs across the board.

If technology is meant to help us do more with less, why are sponsors (like pharma, biotech, and medtech companies) and CROs still spending more and working harder? It’s not due to increased protocol complexity. The real issue is that the clinical tech space got comfortable with high-margin, web-only systems and didn’t invest in building truly modern, mobile-first platforms designed for remote data capture and DHTs.

Today’s demand for decentralized and hybrid trials, driven by FDA guidance, is clear. These models promise better efficiency by combining site-based and remote patient data. But in practice, many platforms fall short. Without truly unified solutions that work seamlessly across web and mobile, sponsors and CROs are facing higher costs and longer timelines.

To meet hybrid trial demands, CROs are often forced to “stitch together” different technologies using APIs, combining separate web and mobile platforms. This leads to delays, added costs, and complex revalidations across systems. What’s needed is a unified platform—a single system with one code base, one database, and fully integrated mobile and web tools. That’s what we mean by unified: no integrations, no duplication, just one platform that works end-to-end.

After 15 years of investment in web and mobile innovations, Crucial Data Solutions is stepping forward to help the industry modernize. We’re introducing a new subscription-based pricing model that gives customers full access to all TrialKit platform tools with no hidden fees or complex contracts. Pricing is based on the number of studies, with simple monthly tiers.

Here’s how it works: 

• Pay a one-time startup fee of $25,000 for a single study
• Choose a monthly subscription starting at $1,350/month
• Pricing scales across 10 tiers, up to unlimited studies for $90,000/month
• As your study volume increases, your cost per study can drop to under $500/month

There’s no need for lengthy RFPs or study-by-study negotiations. Customers can launch studies faster and manage them directly, configuring everything themselves with support when needed. We’ll build the first study with you, support the second, and train your team as you grow. This model builds on our 15-year track record. More than 40,000 users have built over 10,000 studies with TrialKit, helping us become profitable and debt-free—all without venture capital.

We’re able to offer this because TrialKit is the only platform that lets customers fully configure and manage all clinical products using a single drag-and-drop tool. It runs across web, native iOS, and Android, supports AI-driven reporting and analysis, and can be translated and white-labeled for your organization.

Ready to modernize your clinical trials without the complexity or inflated costs?

Explore our transparent, tiered pricing model and see how TrialKit makes advanced, end-to-end clinical research accessible and affordable.